Jane Street
ARKG icon

Jane Street’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jane Street’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Sell
44,710
-51,625
-54% -$1.64M ﹤0.01% 5277
2026
Q1 		$2.55M Sell
96,335
-484,079
-83% -$14.2M ﹤0.01% 4647
2025
Q4 		$16.8M Buy
580,414
+210,102
+57% +$6.31M ﹤0.01% 1778
2025
Q3 		$10.3M Buy
370,312
+230,544
+165% +$5.83M ﹤0.01% 2386
2025
Q2 		$3.4M Buy
139,768
+91,987
+193% +$2.02M ﹤0.01% 3563
2025
Q1 		$992K Sell
47,781
-289,801
-86% -$7.28M ﹤0.01% 5592
2024
Q4 		$7.95M Buy
337,582
+115,219
+52% +$2.84M ﹤0.01% 2110
2024
Q3 		$5.69M Buy
222,363
+171,633
+338% +$4.37M ﹤0.01% 2652
2024
Q2 		$1.19M Sell
50,730
-62,717
-55% -$1.58M ﹤0.01% 5450
2024
Q1 		$3.26M Buy
113,447
+22,313
+24% +$671K ﹤0.01% 3262
2023
Q4 		$2.99M Buy
91,134
+20,704
+29% +$563K ﹤0.01% 3644
2023
Q3 		$1.96M Buy
+70,430
New +$2.3M ﹤0.01% 4082
2023
Q2 		– Sell
-14,974
Closed -$471K – 8635
2023
Q1 		$450K Sell
14,974
-105,170
-88% -$3.26M ﹤0.01% 6496
2022
Q4 		$3.39M Buy
+120,144
New +$3.81M ﹤0.01% 3031
2022
Q3 		– Sell
-43,660
Closed -$1.6M – 9647
2022
Q2 		$1.38M Sell
43,660
-145,606
-77% -$5.09M ﹤0.01% 4879
2022
Q1 		$8.69M Sell
189,266
-288,780
-60% -$13.8M ﹤0.01% 2167
2021
Q4 		$29.3M Buy
478,046
+61,689
+15% +$4.26M 0.01% 935
2021
Q3 		$31.1M Buy
416,357
+141,907
+52% +$11.9M 0.01% 830
2021
Q2 		$25.4M Buy
274,450
+142,126
+107% +$12.1M 0.01% 907
2021
Q1 		$11.7M Sell
132,324
-637,238
-83% -$63.2M 0.01% 1404
2020
Q4 		$71.8M Buy
769,562
+742,809
+2,777% +$59.2M 0.04% 338
2020
Q3 		$1.7M Buy
+26,753
New +$1.57M ﹤0.01% 3286
2020
Q2 		– Sell
-30,371
Closed -$950K – 7033
2020
Q1 		$950K Sell
30,371
-18,205
-37% -$608K ﹤0.01% 2848
2019
Q4 		$1.63M Buy
48,576
+6,046
+14% +$192K ﹤0.01% 2184
2019
Q3 		$1.25M Buy
42,530
+13,897
+49% +$452K ﹤0.01% 2324
2019
Q2 		$987K Sell
28,633
-8,462
-23% -$271K ﹤0.01% 2720
2019
Q1 		$1.22M Sell
37,095
-8,030
-18% -$237K ﹤0.01% 2585
2018
Q4 		$1.08M Buy
+45,125
New +$1.27M ﹤0.01% 2443
2018
Q3 		– Sell
-93,178
Closed -$2.71M – 5048
2018
Q2 		$2.71M Buy
93,178
+24,646
+36% +$686K 0.01% 1596
2018
Q1 		$1.76M Buy
68,532
+43,314
+172% +$1.17M ﹤0.01% 2008
2017
Q4 		$618K Sell
25,218
-30,366
-55% -$769K ﹤0.01% 2926
2017
Q3 		$1.46M Buy
+55,584
New +$1.31M ﹤0.01% 1902
2017
Q2 		– Sell
-15,318
Closed -$317K – 4293
2017
Q1 		$317K Sell
15,318
-10,116
-40% -$193K ﹤0.01% 3370
2016
Q4 		$431K Buy
25,434
+2,614
+11% +$46.8K ﹤0.01% 3001
2016
Q3 		$454K Sell
22,820
-23,210
-50% -$434K ﹤0.01% 2868
2016
Q2 		$776K Buy
46,030
+5,846
+15% +$103K ﹤0.01% 2282
2016
Q1 		$705K Buy
40,184
+13,555
+51% +$232K ﹤0.01% 2222
2015
Q4 		$558K Buy
26,629
+8,347
+46% +$166K ﹤0.01% 2362
2015
Q3 		$343K Sell
18,282
-16,731
-48% -$364K ﹤0.01% 2658
2015
Q2 		$807K Buy
35,013
+8,037
+30% +$187K 0.01% 1778
2015
Q1 		$614K Sell
26,976
-10,747
-28% -$244K ﹤0.01% 1846
2014
Q4 		$801K Buy
+37,723
New +$770K 0.01% 1175

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street's ARKG Position: Q2 2026 in Review

Jane Street reduced its ARK Genomic Revolution ETF (ARKG) stake by 54% in Q2 2026, selling an estimated $1.64M and leaving 44,710 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #5277.

Jane Street first reported a position in ARKG in Q4 2014 and has held it in 42 quarters since. The position peaked at $71.8M in Q4 2020. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Jane Street held 44,710 shares of ARK Genomic Revolution ETF worth $1.88M as of Q2 2026.
  • Jane Street sold 51,625 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.64M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5277 holding.
  • Jane Street first reported a position in ARK Genomic Revolution ETF in Q4 2014 and has held it in 42 quarters since.
  • Jane Street's ARK Genomic Revolution ETF position peaked at $71.8M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.